The information below provides a summary of known issues and upcoming changes related to NICE Evidence Services. This information will be updated...
Details, meeting dates and minutes of the independent technology appraisal committees
NICE transparency of spend
The Quality Standards Advisory Committees (QSAC) are independent committees that help to develop our quality standards. We have 3 committees who:...
Axonics SNS has potential to save the NHS around £6,200 per patient if the device lasts more than six years
How we select the subjects for development into information, advice and guidance
NICE research projects and partners.
NICE quality standards set out priority areas for quality improvement in health and social care.
Evidence-based antimicrobial prescribing guidance for primary and secondary care with a focus on bacterial infection and antibiotic use.
Evidence based recommendations on patiromer (Veltassa) for treating hyperkalaemia in adults
NICE's impact on dementia referral, diagnosis and care planning
How NICE's guidance has impacted on supporting carers of adults with dementia
Evidence-based recommendations on sotagliflozin with insulin for treating type 1 diabetes in adults with a body mass index (BMI) of at least 27 kg/m2
Applications close on Wednesday 4 March 2020
To help people access the information they need quickly and easily, we're reviewing how we produce and present guidance.
Jobs at NICE. Includes current vacancies, roles, location and salary information.
We’re looking for a director to lead our new science, evidence and analytics function.
A quick and easy-to-read guide for care home managers about achieving good oral health in care homes.
Everything NICE has said on diagnosing and managing chronic heart failure in adults in an interactive flowchart
Everything NICE has said on chronic kidney disease (renal failure) in an interactive flowchart
This guideline covers diagnosing, monitoring and managing asthma in adults, young people and children. It aims to improve the accuracy of diagnosis, help people to control their asthma and reduce the risk of asthma attacks. It does not cover managing severe asthma or acute asthma attacks.
Evidence-based recommendations on dapagliflozin (Forxiga) with insulin for treating type 1 diabetes not controlled by insulin therapy alone in adults with a BMI
Information, meeting dates and minutes of the medical technologies advisory committee
Find out more about the NICE technology appraisal advisory committee B members and their registered interests
The percentage of women with schizophrenia, bipolar affective disorder or other psychoses under the age of 45 years who have been given information...
The percentage of women with epilepsy aged 18 or over and who have not attained the age of 45 who are taking antiepileptic drugs who have a record of...
This guideline sets out an antimicrobial prescribing strategy for adults with leg ulcer infection. It aims to optimise antibiotic use and reduce antibiotic resistance.
Evidence-based recommendations on Episcissors-60 for mediolateral episiotomy
NICE recommendations on the use of highly specialised technologies are made by an independent advisory committee called the Highly Specialised...
Everything NICE has said on identifying, treating and managing depression in children, young people and adults in an interactive flowchart
Everything NICE has said on antenatal and postnatal mental health in an interactive flowchart
Everything NICE has said on diagnosing and managing type 1 diabetes in adults in an interactive flowchart
Everything NICE has said on diagnosing, monitoring and managing asthma in children, young people and adults in an interactive flowchart
Everything NICE has said on recognising, assessing and managing bipolar disorder in children, young people and adults in an interactive flowchart
Everything NICE has said on diagnosing and managing the epilepsies in adults and children in primary and secondary care in an interactive flowchart
This guideline covers recognising, assessing and treating bipolar disorder (formerly known as manic depression) in children, young people and adults. The recommendations apply to bipolar I, bipolar II, mixed affective and rapid cycling disorders. It aims to improve access to treatment and quality of life in people with bipolar disorder.
This guideline covers recognising, assessing and treating mental health problems in women who are planning to have a baby, are pregnant, or have had a baby or been pregnant in the past year. It covers depression, anxiety disorders, eating disorders, drug- and alcohol-use disorders and severe mental illness (such as psychosis, bipolar disorder and schizophrenia). It promotes early detection and good management of mental health problems to improve women’s quality of life during pregnancy and in the year after giving birth.
The guideline covers diagnosing, treating and managing epilepsy and seizures in children, young people and adults in primary and secondary care. It offers best practice advice on managing epilepsy to improve health outcomes so that people with epilepsy can fully participate in daily life.
The percentage of women, on the register, prescribed an oral or patch contraceptive method in the preceding 12 months who have also received...
Recommendation ID NG149/5 Question What interventions are effective and cost effective at raising awareness of the health risks of damp
Recommendation ID DG38/1 Question The committee recommended that further research is needed to measure the wider effects on public health
Recommendation ID IPG666/1 Question NICE may update this guidance after 3 years or sooner if important new information becomes available
Recommendation ID NG143/8 Question Which signs and symptoms (or combinations of signs and symptoms) predict a diagnosis of Kawasaki disease